I agree with your sentiments @ddwn. I don’t believe the investment (CR) would’ve been made together with Lonza for a US cell manufacturing facility without some hard nosed questions being asked during the previous FDA meetings. Let’s hope that none of us are misreading what’s been going on. Big Pharma leans a lot on the Government processes in the US. There’s huge profits at stake. They have influence over these Committees. Unless you spend the time to delve you may not see their allegiances It’s not like a Therapeutic Guidelines Authority submission hearing in Australia. IMHO
MSB Trading - Aug 2020 on, page-1385
-
- There are more pages in this discussion • 1,000 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |